Skip to NavigationSkip to content

News

0
Gilead image
Gilead will allow generic manufacturers to produce medicine targeting all genotypes of hepatitis C
0
Shire image
FDA fast-tracks Hunter syndrome treatment and approves newly-acquired NPS Pharma’s Natpara 
0
Xarelto image
Watchdog gives final draft guidance in another blood clot indication for Xarelto
0
Novartis image
Swiss pharma giant wins recommendations for blood cancer drug and meningitis B vaccine

Features

The acting deputy chief pharmaceutical officer at NHS England talks to Pharmafile